Clinical trials: Type 1 Diabetes, completed
Diabetes, Diabetes Mellitus, Type 1
The HEADWIND Study - Part 4
To analyse driving behavior of individuals with type 1 diabetes in eu- and mild hypoglycaemia while driving in a real car. Based on the in-vehicle variables, the investigators aim at establishing algorithms capable of…
- Trial name
- NCT05308095
- Testing
- Controlled hypoglycaemic state while driving
- Where
- Switzerland
- Volunteers
- 10 people
- Sponsor
- Insel Gruppe AG, University Hospital Bern
Diabetes Mellitus, Type 1, Complications
Long Term Vascular Changes in Type 1 Diabetes
The main purpose of this study is to investigate progression of late complications of diabetes during the last ten years in a well characterized cohort of type 1 diabetes with a long duration of the disease, and to define factors…
- Conditions
- Diabetes Mellitus, Type 1, Complications, Coronary Heart Disease
- Trial name
- DM09 (NCT00991575)
- Where
- Norway
- Volunteers
- 33 people, healthy volunteers welcome
- Sponsor
- Oslo University Hospital
Type 1 Diabetes
Sleep Optimization to Improve Glycemic Control in Adults With Type 1 Diabetes
Up to 40% of adults with type 1 diabetes have insufficient sleep which is associated with negative health consequences including poor blood glucose control and greater diabetes complications.
- Trial name
- SOPT (NCT04506151)
- Testing
- Sleep-Opt, Healthy Living
- Where
- United States
- Volunteers
- 144 people
- Sponsor
- University of Illinois Chicago
Type1diabetes
Self Efficacy Levels, Attachment Style and Resiliency of Youth With Type 1 Diabetes
This project will assess self-efficacy levels(SE) ,resiliency and attachment style of adolescent with type 1 diabetes and their caregivers.SE and attachment style of patients and parents will be compared with each other as well…
- Trial name
- NCT04172077
- Where
- Canada
- Volunteers
- 170 people
- Sponsor
- The Hospital for Sick Children
Essential Hypertension, Type 2 Diabetes
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1019" and Co-administration of "BR1019-3" and "BR1019-2" in Healthy Volunteers
The purpose of this clinical trial is to evaluate the pharmacokinetics and the safety after administration of "BR1019" and co-administration of "BR1019-3" and "BR1019-2" in healthy volunteers
- Trial name
- NCT06636877
- Testing
- BR1019, BR1019-2, BR1019-3
- Where
- South Korea
- Volunteers
- 52 people, healthy volunteers welcome
- Sponsor
- Boryung Pharmaceutical Co., Ltd
Type 1 Diabetes
Closed Loop Insulin Therapy in Type 1 Diabetics Based on Blood Microdialysis, Online Sensors and an eMPC Algorithm
The EU funded project CLINICIP (Closed Loop Insulin Infusion for Critically Ill Patients) aims to develop a low-risk monitoring and control device which allows maintaining metabolic control in intensive care units.
- Trial name
- NCT00535483
- Where
- Austria
- Volunteers
- 4 people
- Sponsor
- Medical University of Graz
Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
Magnetic Resonance Diagnostics of Diabetic Peripheral Neuropathy
This project aims to develop high field MR techniques to detect nerve lesions in diabetic patients. The MRI findings will be compared to results from conventional evaluations and nerve conduction studies to determine the validity…
- Conditions
- Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diabetic Polyneuropathy, Hereditary Axonal Neuropathy
- Trial name
- NCT01847937
- Where
- 5 sites in Denmark, Germany
- Volunteers
- 115 people, healthy volunteers welcome
- Sponsor
- Aarhus University Hospital
Type 1 Diabetes Mellitus
Feasibility Study Using Zone-MPC Controller, HMS and Technosphere® Insulin Inhalation System From MannnKind Corp
This clinical trial is a feasibility study to assess the performance of an Artificial Pancreas (AP) device using the Artificial Pancreas System (APS©) platform for subjects with type 1 diabetes using rapid-acting insulin as well…
- Trial name
- NCT01874392
- Testing
- Investigational inhaled insulin (Technosphere), Artificial Pancreas (AP) device (APS©)
- Where
- United States
- Volunteers
- 9 people
- Sponsor
- Sansum Diabetes Research Institute
Type 1 Diabetes
Overnight MD-Logic
Study design: Multicenter,randomized, prospective, open label, cross over, six segments, pilot trial to evaluate blood glucose control overnight under closed-loop insulin delivery with MD-Logic Artificial Pancreas (MDLAP) system…
- Trial name
- NCT01238406
- Testing
- MD-logic Artificial Pancreas (MDLAP), Standard treatment with insulin pump
- Where
- 3 sites in Germany, Israel and 1 more
- Volunteers
- 151 people
- Sponsor
- Rabin Medical Center
Type 1 Diabetes
Study of the Effects of Carbohydrate Counting
The investigators hypothesize that non-optimally treated carbohydrate counting-naïve patients with type 1 diabetes can achieve better metabolic control by counting carbohydrates and that the metabolic control can be further…
- Trial name
- NCT01223547
- Testing
- Education
- Where
- Denmark
- Volunteers
- 64 people
- Sponsor
- Hvidovre University Hospital
Type 1 Diabetes, Organ Transplantation
Islet Cell Transplantation in Patients With Type I Diabetes With Previous Kidney Transplantation
This single center phase 2 clinical trial, is designed for confirming the efficacy and safety of sequential islet allotransplantation with steroid free immunosuppression in patients with previous kidney transplantation.
- Conditions
- Type 1 Diabetes, Organ Transplantation, Immunosuppression
- Trial name
- NCT01123187
- Testing
- islet transplantation
- Where
- France
- Volunteers
- 14 people
- Sponsor
- University Hospital, Lille
Type 1 Diabetes
Acceptability of Hybrid Closed-loop Systems in Patients Living With Highly Unbalanced Type 1 Diabetes
While closed-loop insulin delivery (CLID) systems demonstrated safety and effectiveness in patients with unbalanced type 1 diabetes (T1D), no studies have included patients with highly and chronically unbalanced diabetes.
- Trial name
- HCL-VHP (NCT05282264)
- Testing
- device
- Where
- 2 sites in France
- Volunteers
- 66 people
- Sponsor
- Centre Hospitalier Sud Francilien
Type 1 Diabetes Mellitus
Comparison of FiAsp and Aspart During Postprandial Exercise in Adults With Type 1 Diabetes
Hypoglycemia is the main barrier for physical activity practice of patients with type 1 diabetes (T1D). For postprandial exercise, anticipation with meal insulin bolus reduction is the recommended method to reduce…
- Trial name
- NCT03659799
- Testing
- Insulin FiAsp, Insulin Aspart, 60-minutes postprandial exercise
- Where
- Canada
- Volunteers
- 40 people
- Sponsor
- Institut de Recherches Cliniques de Montreal
Type 1 Diabetes Mellitus
Alternative Delivery of Dose Adjustment For Normal Eating (DAFNE) Trial in Patients With Type 1 Diabetes
The best format for the delivery of structured education for adults with Type 1 diabetes is unclear. Currently some hospitals invite their patients to attend a 5 day outpatient course run over one week (Dose Adjustment For Normal…
- Trial name
- NCT01069393
- Testing
- DAFNE course (Timing of delivery of education)
- Where
- 7 sites in United Kingdom
- Volunteers
- 170 people
- Sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
Diabetes Mellitus Type 2
Bridging the Gap by Transitional Care
The purpose of the study is to evaluate patient adherence with discharge diabetes medications up to 120 days following pharmacist counseling during hospital stay about diabetes self management
- Trial name
- NCT01330121
- Testing
- Pharmacist Counseling
- Where
- United States
- Volunteers
- 130 people
- Sponsor
- Cook County Health
Hypoglycemia, Diabetes Mellitus
Clinical Usability of Nasal Glucagon in Treatment of Hypoglycemia in Children and Adolescents
Up to fifty (50) children and adolescents with type 1 diabetes (T1D) aged 4 to ˂18 years at time of enrolment will be selected for inclusion in the study.
- Trial name
- NCT02402933
- Testing
- Nasal Glucagon
- Where
- 3 sites in United States
- Volunteers
- 26 people
- Sponsor
- Eli Lilly and Company
Type 1 Diabetes
Long-Term Treatment Effect of DiaPep277 in Type 1 Diabetes
The study is an open-label extension study, offering patients who participated and completed previous study 901 to continue treatment with DiaPep277 and clinical follow-up, for 2 additional years.
- Trial name
- NCT00644501
- Testing
- DiaPep277
- Where
- 3 sites in Israel
- Volunteers
- 43 people
- Sponsor
- Andromeda Biotech Ltd.
Type 2 Diabetes Mellitus
Study to Evaluate Effects of Probenecid, Rifampin and Verapamil on Bexagliflozin in Healthy Subjects
The purpose of this study is to examine the drug-drug interaction when given the study drug, bexagliflozin, with three commonly prescribed medications, probenecid, verapamil or rifampin.
- Trial name
- NCT03296800
- Testing
- Bexagliflozin, Probenecid, Rifampin
- Where
- United States
- Volunteers
- 48 people, healthy volunteers welcome
- Sponsor
- Theracos
Type 1 Diabetes
The Effect of Online Based Mentoring Program on the Blood Glucose and Satisfaction Score in Type 1 Diabetes Patients
Purpose: To evaluate the effects of online based mentoring program on the blood glucose and satisfaction score in type 1 diabetes patients. Peer group mentoring will be as effective as guidance by the doctors.
- Trial name
- NCT01157611
- Testing
- Mentoring program
- Where
- South Korea
- Volunteers
- 57 people
- Sponsor
- Samsung Medical Center
Type 1 Diabetes Mellitus
Comparison Between Dexcom G5 Mobile Continuous Glucose Monitoring (CGM) System and the FreeStyle Libre Flash Glucose Monitoring System
1. The accuracy of the sensors (Dexcom G5 vs FreeStyle Libre Flash glucose monitoring) will be evaluated by simultaneous wearing of the 2 sensors during 2 weeks.
- Trial name
- NCT03602963
- Testing
- Dexcom G5 Mobile CGM system
- Where
- Belgium
- Volunteers
- 10 people
- Sponsor
- Jessa Hospital
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.